NewsRx

Search our medical news database

Sexual & Reproductive Health

Mirena contraceptive approved in Japan

Published in Women's Health Weekly, March 1st, 2007

The Japanese Ministry of Health, Labour and Welfare (MHLW) has granted marketing approval for Bayer Schering Pharma's long-acting intrauterine contraceptive system Mirena.

The product is expected to be launched in Japan in April 2007 under the trade name Mirena 52mg and will significantly enhance the choice of methods of contraception available to women in Japan.

"In Japan there has been a limited choice in convenient, reliable, and reversible long-acting contraception," said Phil Smits, head of women's healthcare at Bayer Schering Pharma, AG. "We are delighted that with Mirena we can offer women in Japan an innovative long-acting method for...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook